Status:
UNKNOWN
Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Tourette Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quali...
Eligibility Criteria
Inclusion
- Tourette syndrome
- Participants aged 18 years or over
Exclusion
- Participants under legal protection
- Inability to complete questionnaires alone
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06136572
Start Date
December 1 2023
End Date
November 30 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France